SecBot SecBot

SLNCF

Silence Therapeutics plc
OTC· Pharmaceutical Preparations· Inc. X0· CIK 0001479615 Biotech & Drug Discovery
$6.37 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $6.37
Next earnings
Nov 5
in 9 days · EPS est. −$0.07
1 year
+253.9%
from $1.80 · Oct 27
30 days
+59.2%
from $4.00
52-week range
$1.06–6.37
0% from high · low May 20
Avg volume 20D
510
Oct 19 spike 5.6K
Short interest
🔒 Subscribers only
Filing reports
4
analyzed by SecBot
SecBot read BEARISH 4 reports · latest
Balance 3 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 4/4 ·Next Earnings date, Nov 5, 2026
Strongest BEARISH Silence Therapeutics filed a prospectus supplement to activate an at-the-market (ATM) offering of up to…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • EstimatesRISING

    Current-quarter EPS estimate −$5.871 → −$0.067 over 90 days.

  • TrendUPTREND

    44% above its 50-day average. New closing high $6.37 on Oct 26.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
SLNCF Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Aug 10, 2026
Earnings date
SLNCF Q2 2026 Earnings Scheduled — 2026-08-10
Aug 6, 2026
Earnings date
SLNCF Q2 2026 Earnings Scheduled — 2026-08-06
Mar 18, 2026
Earnings date
SLNCF Q4 2025 Earnings Before Market Open — 2026-03-18
Mar 2, 2026
Earnings date
SLNCF Q4 2025 Earnings Before Market Open — 2026-03-02

Earnings setup

Estimates
Nov 5
reports in 9 days
−$0.07
EPS estimate, this quarter
+99%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.07-$0.07–-$0.07+0.0%$20.8K
Next Q-$0.07-$0.07–-$0.07+0.0%$4.5K
Current FY-$0.28-$0.28–-$0.28-1.1%$328.8K
Next FY-$0.28-$0.28–-$0.28-1.4%$760.5K

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 10, 2026 Earnings calendar
SLNCF Q2 2026 Earnings Scheduled — 2026-08-10
May 28, 2026 SEC
Silence Therapeutics' $300M universal shelf registration (including a $100M ATM facility) became effective on May 27…
EFFECT — Impact 5/10
May 27, 2026 SEC
Silence Therapeutics filed a prospectus supplement to activate an at-the-market (ATM) offering of up to $100M in ADSs…
424B5 — Impact 6/10
May 18, 2026 SEC
Silence Therapeutics filed a $300M universal shelf registration statement on Form S-3, including an at-the-market…
S-3 — Impact 6/10

SecBot reports

4 filings · 0 bullish · 3 bearish · 1 neutral
All SLNCF filing & press-release reports (4)